ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,573Medicare Part D Prescriptions Filled, Including Refills

Rank: 298 out of 1107

$687K Total Retail Price of All Prescriptions

Rank: 228 out of 1107

542 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 7,015 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
OMEPRAZOLE 416 265 1 4
LEVOTHYROXINE SODIUM 391 284 2 3
SIMVASTATIN 295 228 3 5
GABAPENTIN 231 110 4 9
ZOLPIDEM TARTRATE 227 135 5 22
NEXIUM 215 130 6 18
FUROSEMIDE 204 159 7 7
HYDROCODONE-ACETAMINOPHEN 196 162 S3 8 1
LISINOPRIL 166 121 9 2
ATENOLOL 164 113 10 19
AMOXICILLIN 160 100 11 90
AMLODIPINE BESYLATE 154 114 12 6
METFORMIN HCL 151 81 13 8
AZITHROMYCIN 143 77 14 35
METOPROLOL TARTRATE 138 89 15 10
IBUPROFEN 136 41 16 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 100 17 24
PREDNISONE 128 90 18 40
GLYBURIDE-METFORMIN HCL 125 73 R 19 165
TRAMADOL HCL 123 79 20 26
TRAMADOL HCL-ACETAMINOPHEN 122 82 21 195
CRESTOR 115 56 22 23
RANITIDINE HCL 112 64 23 21
MELOXICAM 104 85 24 25
LOSARTAN-HYDROCHLOROTHIAZIDE 102 64 25 66
PRAVASTATIN SODIUM 101 74 26 12
ESTRADIOL 101 58 R 26 151
TRIAMCINOLONE ACETONIDE 100 70 28 137
METFORMIN HCL ER 98 62 29 58
CITALOPRAM HBR 92 69 30 17
ATORVASTATIN CALCIUM 85 75 31 13
WARFARIN SODIUM 84 80 32 15
HYDROCHLOROTHIAZIDE 79 62 33 11
NAPROXEN 74 25 34 80
CYCLOBENZAPRINE HCL 74 49 R 34 56
SYMBICORT 72 35 36 124
ADVAIR DISKUS 70 41 37 54
CEPHALEXIN 69 47 38 81
POTASSIUM CHLORIDE 69 61 38 14
PROAIR HFA 68 36 40 37
PAROXETINE HCL 64 42 41 45
CELEBREX 64 34 41 85
MECLIZINE HCL 63 48 43 114
DIOVAN HCT 63 27 43 106
POLYETHYLENE GLYCOL 3350 62 43 45 46
CLOPIDOGREL 61 52 46 28
JANUVIA 59 30 47 60
FLUOXETINE HCL 59 19 47 47
LOSARTAN POTASSIUM 58 30 49 29
SERTRALINE HCL 58 31 49 20
PLAVIX 55 49 51 39
ISOSORBIDE MONONITRATE ER 54 45 52 34
NITROFURANTOIN 54 41 52 238
BISOPROLOL-HYDROCHLOROTHIAZIDE 53 29 54 164
METOPROLOL SUCCINATE 52 41 55 16
FLUCONAZOLE 51 38 56 150
DILTIAZEM 24HR ER 51 47 56 172
VENTOLIN HFA 51 22 56 97
PENICILLIN V POTASSIUM 50 38 59 322
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.